BTIG Maintains Buy on BrainsWay, Raises Price Target to $20

Benzinga Newsdesk www.benzinga.com Positive 75.6%

Neg 0% Neu 0% Pos 75.6%

BTIG analyst Sam Eiber maintains BrainsWay (NASDAQ:BWAY) with a Buy and raises the price target from $18 to $20.

Comments

No comments yet. Be the first!